In other news: > EPFL researchers have demonstrated the first pill-sized bioprinter that can be swallowed and guided within the gastrointestinal tract, where i

In other news: > EPFL researchers have demonstrated the first pill-sized bioprinter that can be swallowed and guided within the gastrointestinal tract, where it directly deposits bio-ink over damaged tissues to support repair. https://actu.epfl.ch/news/a-pill-that-prints-2/ https://actu.epfl.ch/news/a-pill-that-prints-2/